202 related articles for article (PubMed ID: 28152594)
1. Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters.
Abe Y; Nagano M; Tada A; Adachi J; Tomonaga T
J Proteome Res; 2017 Feb; 16(2):1077-1086. PubMed ID: 28152594
[TBL] [Abstract][Full Text] [Related]
2. Phosphotyrosine proteomic study of interferon alpha signaling pathway using a combination of immunoprecipitation and immobilized metal affinity chromatography.
Zheng H; Hu P; Quinn DF; Wang YK
Mol Cell Proteomics; 2005 Jun; 4(6):721-30. PubMed ID: 15659558
[TBL] [Abstract][Full Text] [Related]
3. Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.
Tong J; Taylor P; Jovceva E; St-Germain JR; Jin LL; Nikolic A; Gu X; Li ZH; Trudel S; Moran MF
J Proteome Res; 2008 Mar; 7(3):1067-77. PubMed ID: 18271526
[TBL] [Abstract][Full Text] [Related]
4. Development of a 5-plex SILAC method tuned for the quantitation of tyrosine phosphorylation dynamics.
Tzouros M; Golling S; Avila D; Lamerz J; Berrera M; Ebeling M; Langen H; Augustin A
Mol Cell Proteomics; 2013 Nov; 12(11):3339-49. PubMed ID: 23882028
[TBL] [Abstract][Full Text] [Related]
5. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Haake SM; Li J; Bai Y; Kinose F; Fang B; Welsh EA; Zent R; Dhillon J; Pow-Sang JM; Chen YA; Koomen JM; Rathmell WK; Fishman M; Haura EB
Clin Cancer Res; 2016 Nov; 22(22):5605-5616. PubMed ID: 27220961
[TBL] [Abstract][Full Text] [Related]
7. Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.
Yamasaki F; Johansen MJ; Zhang D; Krishnamurthy S; Felix E; Bartholomeusz C; Aguilar RJ; Kurisu K; Mills GB; Hortobagyi GN; Ueno NT
Cancer Res; 2007 Jun; 67(12):5779-88. PubMed ID: 17575145
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.
Zhang G; Fang B; Liu RZ; Lin H; Kinose F; Bai Y; Oguz U; Remily-Wood ER; Li J; Altiok S; Eschrich S; Koomen J; Haura EB
J Proteome Res; 2011 Jan; 10(1):305-19. PubMed ID: 21080693
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.
van der Mijn JC; Labots M; Piersma SR; Pham TV; Knol JC; Broxterman HJ; Verheul HM; Jiménez CR
J Proteomics; 2015 Sep; 127(Pt B):259-63. PubMed ID: 25890253
[TBL] [Abstract][Full Text] [Related]
10. Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab.
Abe Y; Nagano M; Kuga T; Tada A; Isoyama J; Adachi J; Tomonaga T
Sci Rep; 2017 Sep; 7(1):10463. PubMed ID: 28874695
[TBL] [Abstract][Full Text] [Related]
11. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
12. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
[TBL] [Abstract][Full Text] [Related]
13. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
Rush J; Moritz A; Lee KA; Guo A; Goss VL; Spek EJ; Zhang H; Zha XM; Polakiewicz RD; Comb MJ
Nat Biotechnol; 2005 Jan; 23(1):94-101. PubMed ID: 15592455
[TBL] [Abstract][Full Text] [Related]
14. Integration of proteomic analyses to monitor the activity status of phosphorylation signaling.
Nagano K; Shinkawa T; Yabuki N; Mutoh H; Inomata N; Watanabe Y; Ashihara M; Nagahashi S; Ishii N; Aoki Y; Haramura M
J Proteomics; 2011 Mar; 74(3):319-26. PubMed ID: 21118733
[TBL] [Abstract][Full Text] [Related]
15. Use of detergents to increase selectivity of immunoprecipitation of tyrosine phosphorylated peptides prior to identification by MALDI quadrupole-TOF MS.
Zhang G; Neubert TA
Proteomics; 2006 Jan; 6(2):571-8. PubMed ID: 16342243
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Phosphotyrosine Signaling Networks in Lung Cancer Cell Lines.
Broncel M; Huang PH
Methods Mol Biol; 2017; 1636():253-262. PubMed ID: 28730484
[TBL] [Abstract][Full Text] [Related]
17. Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells.
Weber C; Schreiber TB; Daub H
J Proteomics; 2012 Feb; 75(4):1343-56. PubMed ID: 22115753
[TBL] [Abstract][Full Text] [Related]
18. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer.
McKinley ET; Liu H; McDonald WH; Luo W; Zhao P; Coffey RJ; Hanks SK; Manning HC
PLoS One; 2013; 8(11):e80207. PubMed ID: 24260357
[TBL] [Abstract][Full Text] [Related]
19. Automated Enrichment of Phosphotyrosine Peptides for High-Throughput Proteomics.
Chang A; Leutert M; Rodriguez-Mias RA; Villén J
J Proteome Res; 2023 Jun; 22(6):1868-1880. PubMed ID: 37097255
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia.
Tong J; Helmy M; Cavalli FM; Jin L; St-Germain J; Karisch R; Taylor P; Minden MD; Taylor MD; Neel BG; Bader GD; Moran MF
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28176486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
